Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003
Prevalence of erythromycin resistance in lower airway bacterial isolates from patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005
Pseudomonas aeruginosa drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasisSource: Eur Respir J 2001; 18: Suppl. 33, 541s Year: 2001
Evolution of antimicrobial susceptibility of respiratory isolates in chronic obstructive pulmonary patients diagnosed of acquired community pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD) Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa Year: 2009
Prevalence and antibiotic susceptibility of pathogens from analysis of respiratory samples Source: Eur Respir J 2007; 30: Suppl. 51, 405s Year: 2007
Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007
Spectrum of bacterial and viral pathogens of infectious exacerbation of COPD Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
The effect of clarithromycin on immunity of mice with chronic respiratory infection caused by P. aeruginosa Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Antibacterial activity of telithromycin (TEL) and comparators against bacterial pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in the PROTEKT study 1999–2002 Source: Eur Respir J 2004; 24: Suppl. 48, 641s Year: 2004
Incidence of different pathogenic microorganisms and antibiotic susceptibility in a respiratory diseases unit Source: Eur Respir J 2004; 24: Suppl. 48, 638s Year: 2004
Antibiotics resistance of the gram-negative pathogens of bacterial respiratory infections (RI) in Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 787s Year: 2006
Antibiotics and new guidelines for the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175 Year: 2004
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Potential antibiotic resistant pathogens in community-acquired pneumonia: playing it safe is anything but Source: Eur Respir J, 54 (1) 1900870; 10.1183/13993003.00870-2019 Year: 2019
Gram-negative enterobacteria in the etiological structure of COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
An experience of moxifloxacin (MOX) use in therapy of nosocomial pneumonia (NP) in patients who hadn‘t risk factors to be infected by Pseudomonas aeruginosa Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005
Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015